Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programme.

Davidson M, Aronson LI, Howard-Reeves J, Bryant H, Cutts RJ, Hulkki-Wilson S, Kouvelakis K, Kalaitzaki E, Watkins D, Starling N, Rao S, Cardenosa ML, Begum R, Rana I, Lazaro-Alcausi R, Terlizzo M, Wotherspoon A, Brown G, Swansbury J, Lord CJ, Cunningham D, Chau I, Chong IY.

Eur J Cancer. 2019 Nov;122:12-21. doi: 10.1016/j.ejca.2019.09.003. Epub 2019 Oct 10.

PMID:
31606655
3.

Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.

Zhu Y, Lu D, Lira ME, Xu Q, Du Y, Xiong J, Mao M, Chung HC, Zheng G.

Exp Mol Pathol. 2016 Apr;100(2):287-93. doi: 10.1016/j.yexmp.2015.11.027. Epub 2015 Nov 25.

PMID:
26626802
4.

Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues.

Tantiwetrueangdet A, Panvichian R, Wongwaisayawan S, Sueangoen N, Lertsithichai P.

Med Oncol. 2018 Oct 3;35(12):149. doi: 10.1007/s12032-018-1210-8.

5.
6.

Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples.

Somasundaram DB, Aravindan S, Yu Z, Jayaraman M, Tran NTB, Li S, Herman TS, Aravindan N.

BMC Cancer. 2019 Jan 28;19(1):106. doi: 10.1186/s12885-019-5306-0.

7.

Detection of HER2 amplification in formalin-fixed paraffin-embedded breast carcinoma tissue with digital PCR using two TFF3 sequences as internal reference.

Yu R, Xuan W, Zhou L, Luo Y, Liu X, Xiong P, Ren X.

Exp Mol Pathol. 2018 Jun;104(3):235-238. doi: 10.1016/j.yexmp.2018.04.004. Epub 2018 Apr 30.

PMID:
29715436
8.

Droplet digital PCR measurement of HER2 in patients with gastric cancer.

Kinugasa H, Nouso K, Tanaka T, Miyahara K, Morimoto Y, Dohi C, Matsubara T, Okada H, Yamamoto K.

Br J Cancer. 2015 May 12;112(10):1652-5. doi: 10.1038/bjc.2015.129. Epub 2015 Apr 21.

9.

Prognostic relevance of gene amplifications and coamplifications in breast cancer.

Al-Kuraya K, Schraml P, Torhorst J, Tapia C, Zaharieva B, Novotny H, Spichtin H, Maurer R, Mirlacher M, Köchli O, Zuber M, Dieterich H, Mross F, Wilber K, Simon R, Sauter G.

Cancer Res. 2004 Dec 1;64(23):8534-40.

10.

Fluorescence In Situ Hybridization (FISH) or Other In Situ Hybridization (ISH) Testing of Uterine Cervical Cells to Predict Precancer and Cancer [Internet].

Uhlig K, Earley A, Lamont J, Dahabreh IJ, Avendano EE, Cowan JM, Feldman S.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Feb 16.

11.

Digital polymerase chain reaction for detecting c-MYC copy number gain in tissue and cell-free plasma samples of colorectal cancer patients.

Lee KS, Nam SK, Seo SH, Park KU, Oh HK, Kim DW, Kang SB, Kim WH, Lee HS.

Sci Rep. 2019 Feb 7;9(1):1611. doi: 10.1038/s41598-018-38415-4.

12.
13.

[Clinical value of droplet digital polymerase chain reaction method in detecting plasma circulating tumor deoxyribonucleic acid epidermal growth factor receptor mutations in advanced pulmonary adenocarcinoma patients].

Ma L, Lü JL, Li K, Wang JH, Yang XJ, Li X, Zhang H, Zhang Q, Qin N, Zhang SC.

Zhonghua Yi Xue Za Zhi. 2018 Aug 7;98(29):2336-2340. doi: 10.3760/cma.j.issn.0376-2491.2018.29.012. Chinese.

PMID:
30107692
14.

Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR.

Sartelet H, Grossi L, Pasquier D, Combaret V, Bouvier R, Ranchère D, Plantaz D, Munzer M, Philip T, Birembaut P, Zahm JM, Bergeron C, Gaillard D, Pasquier B.

J Pathol. 2002 Sep;198(1):83-91.

PMID:
12210067
15.

Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.

Yasojima H, Shimomura A, Naoi Y, Kishi K, Baba Y, Shimazu K, Nakayama T, Kim SJ, Tamaki Y, Noguchi S.

Eur J Cancer. 2011 Aug;47(12):1779-88. doi: 10.1016/j.ejca.2011.06.017. Epub 2011 Jul 7.

PMID:
21741827
16.

Comparative polymerase chain reaction analysis of c-myc amplification on archival breast fine-needle aspiration materials.

Rao JY, Apple SK, Jin Y, Lin S, Nieberg RK, Hirtschowitz SL.

Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):175-9.

17.

Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH.

Das K, Gunasegaran B, Tan IB, Deng N, Lim KH, Tan P.

Cancer Lett. 2014 Oct 28;353(2):167-75. doi: 10.1016/j.canlet.2014.07.021. Epub 2014 Jul 30.

PMID:
25086186
18.

Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.

Takei H, Nguyen Y, Mehta V, Chintagumpala M, Dauser RC, Adesina AM.

J Neurosurg Pediatr. 2009 Jan;3(1):61-5. doi: 10.3171/2008.10.PEDS08105.

PMID:
19119907
19.

HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.

Al-Kuraya K, Novotny H, Bavi P, Siraj AK, Uddin S, Ezzat A, Sanea NA, Al-Dayel F, Al-Mana H, Sheikh SS, Mirlacher M, Tapia C, Simon R, Sauter G, Terracciano L, Tornillo L.

J Clin Pathol. 2007 Jul;60(7):768-72. Epub 2006 Aug 1.

20.

Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue.

Belgrader P, Tanner SC, Regan JF, Koehler R, Hindson BJ, Brown AS.

Clin Chem. 2013 Jun;59(6):991-4. doi: 10.1373/clinchem.2012.197855. Epub 2013 Jan 28.

Supplemental Content

Support Center